Bioceres Crop Solutions Corp (BIOX)

Currency in USD
1.29
-0.04(-3.01%)
Closed·
1.22-0.07(-5.43%)
·
Unusual Post-Market activity
BIOX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.291.40
52 wk Range
1.177.44
Key Statistics
Prev. Close
1.33
Open
1.35
Day's Range
1.29-1.4
52 wk Range
1.17-7.44
Volume
219.65K
Average Volume (3m)
608.56K
1-Year Change
-81.2772%
Book Value / Share
4.12
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIOX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.00
Upside
+55.04%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell

Bioceres Crop Solutions Corp Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

Industry
Chemicals
Employees
751

Bioceres Crop Solutions Corp Earnings Call Summary for Q1/2026

  • Bioceres Crop Solutions Corp (BIOX) reported Q1 2025 EPS of -$0.1183 (494.33% below forecast) and revenue of $77.5 million (26.19% below forecast), causing a 3.11% stock drop
  • Despite a 17% year-over-year revenue decline, the company improved gross margin to 47% (from 40%) and increased adjusted EBITDA by 61% to $13.6 million
  • CEO Federico Trucco cited 'complex environment' challenges, particularly in Argentina where tight credit conditions have suppressed demand
  • The company maintains high debt levels with net financial debt of $225.9 million and a net debt-to-adjusted EBITDA ratio of 6.8x
  • Management forecasts continued seed segment revenue declines for the next two quarters, but expects improvement from Corteva biostimulant sales later in the year
Last Updated: 11/13/2025, 10:04 PM
Read Full Transcript

Compare BIOX to Peers and Sector

Metrics to compare
BIOX
Peers
Sector
Relationship
P/E Ratio
−1.5x5.9x1.7x
PEG Ratio
0.00−0.020.00
Price/Book
0.3x1.4x1.6x
Price / LTM Sales
0.3x1.2x1.4x
Upside (Analyst Target)
55.0%84.2%14.9%
Fair Value Upside
Unlock0.8%−2.6%Unlock

Analyst Ratings

0 Buy
3 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 2.00
(+55.04% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Canaccord Genuity
Hold2.00+55.04%2.25MaintainDec 31, 2025
Canaccord Genuity
Hold2.25+74.42%2.50MaintainNov 14, 2025
Oppenheimer
Hold---DowngradeOct 22, 2025
Canaccord Genuity
Hold2.50+93.80%6.50DowngradeSep 10, 2025
Lake Street Capital Markets
Buy5.00+287.60%8.00MaintainSep 09, 2025

Earnings

Latest Release
Nov 12, 2025
EPS / Forecast
-0.1183 / 0.03
Revenue / Forecast
77.50M / 105.00M
EPS Revisions
Last 90 days

BIOX Income Statement

People Also Watch

68.20
GLOB
+1.07%
34.310
YPF
+1.75%
3.560
SATL
+2.01%
49.040
VIST
+0.39%
15.290
CEPU
-1.42%

FAQ

What Is the Bioceres Crop (BIOX) Stock Price Today?

The Bioceres Crop stock price today is 1.29

What Stock Exchange Does Bioceres Crop Trade On?

Bioceres Crop is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Bioceres Crop?

The stock symbol for Bioceres Crop is "BIOX."

What Is the Bioceres Crop Market Cap?

As of today, Bioceres Crop market cap is 81.89M.

What Is Bioceres Crop's Earnings Per Share (TTM)?

The Bioceres Crop EPS (TTM) is -0.89.

When Is the Next Bioceres Crop Earnings Date?

Bioceres Crop will release its next earnings report on Feb 04, 2026.

From a Technical Analysis Perspective, Is BIOX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Bioceres Crop Stock Split?

Bioceres Crop has split 0 times.

How Many Employees Does Bioceres Crop Have?

Bioceres Crop has 751 employees.

What is the current trading status of Bioceres Crop (BIOX)?

As of Jan 19, 2026, Bioceres Crop (BIOX) is trading at a price of 1.29, with a previous close of 1.33. The stock has fluctuated within a day range of 1.29 to 1.40, while its 52-week range spans from 1.17 to 7.44.

What Is Bioceres Crop (BIOX) Price Target According to Analysts?

The average 12-month price target for Bioceres Crop is USD2, with a high estimate of USD2 and a low estimate of USD2. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +55.04% Upside potential.

What Is the BIOX After Hours Price?

BIOX's last after hours stock price is 1.22, the stock has decreased by -0.07, or -5.43%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.